Alexza (ALXA) Receives CRL From FDA On AZ-004 Stating It is Not Ready for Approval, Shares Plunge
Tweet Send to a Friend
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) received a Complete Response Letter (CRL) from the FDA regarding its NDA for AZ-004 for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
